Enzygnost Anti-HBs II - SFDA Registration ME0000001481SFDAA00841
Access comprehensive regulatory information for Enzygnost Anti-HBs II in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List A device is registered with Saudi Arabia SFDA under registration number ME0000001481SFDAA00841 and manufactured by Siemens Healthcare diagnostics products Gmbh.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
for the qualitative detection and quantitative determination of hepatitis B
Enzyme immunoassay for the qualitative detection and quantitative determination of specific antibodies to the hepatitis B surface antigen (HBsAg) in human serum and plasma. The enzyme immunoassay can be processed using the ELISA processors, BEP® III System, BEP® 2000 System or the BEP 2000 Advance® System. A non-automated processing of the test is also possible
[]